New Oral Direct-Acting Antiviral Agents for Treatment of Chronic Hepatitis-C Infection in Patients With Chronic Kidney Disease Including Dialysis Patients and Kidney Transplant Recipients

SM Journal of Nephrology and Therapeutics

doi 10.36876/smjnt.1007